Pharming (PHAR) Gross Margin (2020 - 2025)
Historic Gross Margin for Pharming (PHAR) over the last 6 years, with Q3 2025 value amounting to 106.88%.
- Pharming's Gross Margin rose 159900.0% to 106.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 89.9%, marking a year-over-year increase of 12300.0%. This contributed to the annual value of 88.09% for FY2024, which is 16300.0% down from last year.
- According to the latest figures from Q3 2025, Pharming's Gross Margin is 106.88%, which was up 159900.0% from 89.96% recorded in Q2 2025.
- In the past 5 years, Pharming's Gross Margin registered a high of 106.88% during Q3 2025, and its lowest value of 32.44% during Q3 2021.
- For the 5-year period, Pharming's Gross Margin averaged around 87.13%, with its median value being 89.48% (2025).
- As far as peak fluctuations go, Pharming's Gross Margin plummeted by -570700bps in 2021, and later surged by 633100bps in 2022.
- Over the past 5 years, Pharming's Gross Margin (Quarter) stood at 89.91% in 2021, then fell by -2bps to 88.46% in 2022, then grew by 3bps to 91.26% in 2023, then dropped by -5bps to 86.82% in 2024, then increased by 23bps to 106.88% in 2025.
- Its Gross Margin was 106.88% in Q3 2025, compared to 89.96% in Q2 2025 and 89.48% in Q1 2025.